| | |
| Clinical data | |
|---|---|
| Other names | Homoquinolinate |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| PDB ligand | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.164.902 |
| Chemical and physical data | |
| Formula | C8H7NO4 |
| Molar mass | 181.147 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Homoquinolinic acid (HQA) is a potent excitotoxin [1] that is a conformationally restricted analogue of N-methyl-D-aspartate (NMDA) and a partial agonist of the main/glutamate site of the NMDA receptor, with some selectivity for NR2B subunit-containing receptors. [2] [3] [4] It is approximately equipotent to NMDA and about five times more potent than quinolinic acid as an agonist of the NMDA receptor. [5] HQA has also been found to label a novel yet uncharacterized binding site, which can be distinguished from the NMDA receptor with the use of 2-carboxy-3-carboxymethylquinoline (CCMQ), a selective ligand of the uncharacterized site. [6]